Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world is not on track to meet the ambitious ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

Accurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.

Vision Group has joined the fight against HIV/AIDS by contributing Sh100 million as a sponsor of this year’s Kabaka Birthday Run.The event precedes the celebrations of the Kabaka’s birthday and aims ...